Clinical Trial: Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: A Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients in India
Brief Summary:
TRACE is a Multicentre Retrospective Study planned to gather follow up data for a period of 1 year in order to understand anti-thrombotic management patterns and outcomes of Acute Coronary Syndrome patients in India.
This retrospective study is designed to provide a rapid and quick analysis of the existing database of ACS patients. So as to ensure quality check in the study, a pilot study will be conducted with around 500 patients at 10 centres across India and based on the meaningful results of the pilot study, full retrospective multi-centric study will be initiated at various selected centres across India. This study will use available registry data from a defined time period of Jan 2007-Dec 2009.
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome:
- Anti thrombotic strategies used in ACS patients [ Time Frame: Jan 2007-Dec 2009 ]
- Anti-thrombotic treatment strategies in a `real-life' observational setting across different sites in India. [ Time Frame: Jan 2007-Dec 2009 ]
Original Primary Outcome: Same as current
Current Secondary Outcome: ACS outcomes with respect to: -Revascularization -Angina/ Re-infarction -Cardiogenic shock/Heart failure/Cardiac arrest -Atrial fibrillation/flutter -Ventricular Fibrillation/ Sustained V Tachycardia -Stroke -Mortality -Bleeding [ Time Frame: Jan 2007-Dec 2009 ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: January 20, 2011
Date Started: February 2011
Date Completion:
Last Updated: January 31, 2012
Last Verified: January 2012
